B
Boston Scientific Corporation BSX
$105.87 -$0.52-0.49% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 18.25% 19.08% 20.68% 44.75% -34.55%
Total Depreciation and Amortization 3.38% -6.61% 13.73% -1.61% 2.30%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -136.36% 0.92% 257.38% -84.24% 258.33%
Change in Net Operating Assets 134.37% -309.26% 95.18% 179.43% 71.87%
Cash from Operations 137.71% -62.84% 45.31% 23.25% 395.73%
Capital Expenditure 16.04% 32.49% -54.75% -15.48% 13.41%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -322.18% 93.01% -203.28% -2,247.92% -2.13%
Divestitures -- -- -- -- --
Other Investing Activities 154.05% -572.73% 90.91% -77.94% -15.25%
Cash from Investing -125.20% 86.50% -159.57% -426.57% 4.91%
Total Debt Issued -100.00% 724.34% 759.09% -- -100.00%
Total Debt Repaid 76.05% -- -- -- 100.00%
Issuance of Common Stock -72.17% 310.71% -70.83% 269.23% -67.50%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 55.04% -253.57% 175.68% -5,450.00% 98.43%
Cash from Financing -245.92% 8.88% 2,957.14% -70.83% -98.47%
Foreign Exchange rate Adjustments -94.87% 533.33% -250.00% 700.00% 85.71%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -156.87% 115.31% -396.12% -172.79% -60.72%